SOP Guide for Pharma

Sterile Injectable Manufacturing: SOP for Deviation Management in Quality Assurance – V 2.0

Sterile Injectable Manufacturing: SOP for Deviation Management in Quality Assurance – V 2.0

Standard Operating Procedure for Deviation Management in Quality Assurance


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/084/2025
Supersedes SOP/SIM/084/2022
Page No. Page 1 of 14
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To establish a standard procedure for identifying, documenting, investigating, and resolving deviations encountered in processes, systems, or documentation related to sterile injectable manufacturing operations, ensuring consistent product quality and regulatory compliance.

2. Scope

This SOP applies to all planned and unplanned deviations observed in manufacturing, packaging, quality

control, quality assurance, and warehouse operations within the sterile injectable manufacturing unit.

3. Responsibilities

  • Initiator: Identifies and reports deviation by filling out the deviation form.
  • QA Executive: Logs, reviews, investigates, and tracks deviations; ensures CAPA initiation.
  • Department Head: Provides investigation support and ensures CAPA implementation.
  • QA Manager: Reviews and approves investigation and CAPA; decides on batch disposition.

4. Accountability

Head – Quality Assurance is accountable for effective deviation management, ensuring closure within the stipulated time and compliance with GMP standards.

5. Procedure

5.1 Deviation Identification and Initiation

  1. Deviation may be identified during any operation, audit, or quality check.
  2. The concerned person must inform the supervisor and QA immediately.
  3. Fill out the Deviation Form (Annexure-1) and submit to QA within 24 hours of detection.

5.2 Deviation Logging and Numbering

  1. QA assigns a unique deviation number in the Deviation Register (Annexure-2).
  2. Number format: DEV/DEPT/XXX/YY (e.g., DEV/MFG/045/25).

5.3 Deviation Classification

  1. QA classifies deviations as:
    • Critical: May affect product quality/safety.
    • Major: Significant process/documentation lapses with potential indirect impact.
    • Minor: Low-risk procedural lapses.

5.4 Investigation and Impact Assessment

  1. QA, along with the department head, conducts root cause analysis using tools such as 5-Why or Fishbone diagram.
  2. Assess product impact, batch status, and regulatory reporting requirement.
  3. Document findings in Deviation Investigation Report (Annexure-3).

5.5 Corrective and Preventive Actions (CAPA)

  1. Responsible person proposes CAPA using CAPA Form (Annexure-4).
  2. QA verifies and tracks CAPA implementation within 30 days.
  3. Re-train employees where required and update related SOPs.

5.6 Deviation Closure

  1. QA reviews CAPA completion and effectiveness check.
  2. Update Deviation Closure Status Log (Annexure-5).
  3. Deviation must be closed within 30 working days. If not, justify with reasons and revised timeline.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • GMP: Good Manufacturing Practices

7. Documents

  1. Deviation Form – Annexure-1
  2. Deviation Register – Annexure-2
  3. Deviation Investigation Report – Annexure-3
  4. CAPA Form – Annexure-4
  5. Deviation Closure Status Log – Annexure-5

8. References

  • WHO TRS 986 Annex 2 – GMP Guidelines
  • ICH Q9 – Quality Risk Management
  • 21 CFR Part 211 – Subpart F (Production and Process Controls)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Deviation Form

Deviation No. DEV/MFG/045/25
Date 10/06/2025
Department Manufacturing
Description pH meter calibration missed
Initiator Rajesh Kumar

Annexure-2: Deviation Register

Deviation No. Date Department Status
DEV/MFG/045/25 10/06/2025 Manufacturing Open

Annexure-3: Deviation Investigation Report

Root Cause Missed schedule in calendar
Impact None, instrument not used
Investigator Sunita Reddy

Annexure-4: CAPA Form

Corrective Action Re-train staff
Preventive Action Setup alert system for calibration
Responsible Person Anita Mehta

Annexure-5: Deviation Closure Status Log

Deviation No. Closure Date Verified By Status
DEV/MFG/045/25 25/06/2025 QA Officer Closed

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial version New SOP implementation QA Head
18/06/2025 2.0 Updated with annexures and CAPA workflow Annual review QA Head
Exit mobile version